BackFirst Tracks Biotherapeutics Ordinary Shares When-Issued Overview

First Tracks Biotherapeutics Ordinary Shares When-Issued Long Term Debt

Track First Tracks Biotherapeutics Ordinary Shares When-Issued's long-term debt ($1.4M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$1.35M

Peer trimmed avg / median

Loading

First Tracks Biotherapeutics Ordinary Shares When-Issued Long Term Debt History

Loading

First Tracks Biotherapeutics Ordinary Shares When-Issued vs. peers: Long Term Debt Comparison

Loading

First Tracks Biotherapeutics Ordinary Shares When-Issued Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

First Tracks Biotherapeutics Ordinary Shares When-Issued (TRAXV) FAQ

As of the most recent data (September 2026), TRAXV shows a long-term debt of $1.4M. Scroll down for historical charts and peer comparison views.

Tracking TRAXV's long-term debt over time shows whether First Tracks Biotherapeutics Ordinary Shares When-Issued is scaling, shrinking, or reshaping that part of the business. The current reading is $1.4M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has First Tracks Biotherapeutics Ordinary Shares When-Issued's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $1.4M) with ownership activity and broader fundamentals.

First Tracks Biotherapeutics Ordinary Shares When-Issued's long-term debt is $1.4M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.